InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Daly Jason B.. Director active across 1 company, notably Amneal Pharmaceuticals, Inc.. In total, 7 disclosures have been published. Breakdown: 0 buy · 3 sells. Total volume traded: €826k. History available since 3 March 2023. The latest transaction was filed on 5 March 2025 (Cession). Regulator: SEC (Form 4). The full history is free.
7 of 7 declarations